000			03082nam a22003858i 4500
001			zzv350 b1853231
003			DLC
005			20231102192126.0
008			220523t20232023cau b 001 0 eng
010			_a2022023732
020			_a0520388712 (paperback)
020			_a9780520388710 (paperback)
040			_aCU-S/DLC _beng _erda _cDLC _dMiTN
050		4	_aHD9666.4 _b.R58 2023
100	1		_aRoy, Victor, _d1986-
245	1	0	_aCapitalizing a cure : _bhow finance controls the price and value of medicines / _cVictor Roy.
263			_a2301.
264		1	_aOakland, California : _bUniversity of California Press, _c[2023]
264		4	_cA2023.
300			_apages cm.
336			_atext _btxt _2rdacontent.
337			_aunmediated _bn _2rdamedia.
338			_avolume _bnc _2rdacarrier.
504			_aIncludes bibliographical references and index.
505	0		_aPreface : pandemics, Wall Street, and the value playbook -- Introduction : the politics of drug pricing and the value of a cure -- Capitalizing science : public knowledge into pharmaceutical assets -- Capitalizing drugs : shareholder power and the cannibalizing company -- Capitalizing health : the struggle over value and treatment access -- From financialization to public purpose for health -- Conclusion : reckoning with pharmaceutical value in crisis times.
520			_a"Capitalizing a Cure takes us into the struggle over accessing a medical breakthrough to investigate the power of finance over business, biomedicine, and public health. When sofosbuvir-based medicines launched in 2013, they promised a cure for millions ofpatients worldwide with hepatitis C. But their sticker shock-the drug was dubbed "the $1,000-a-day pill"-intensified a global debate over the pricing of new medicines. Weaving extensive historical research with insights from political economy and scienceand technology studies, Victor Roy demystifies an oft-missed dynamic in this debate: the reach of financialized capitalism into how medicines are made, priced, and valued. His account travels between public and private labs, Wall Street and corporate boardrooms, public health meetings and health centers to trace the ways sofosbuvir-based medicines became financial assets dominated by strategies of speculation and extraction at the expense of access and care. Provocative and sobering, this book illuminates the harmful impact of allowing financial markets to supersede democracy and human health and points to the necessary work of building more equitable futures"-- _cProvided by publisher.
610	2	0	_aGilead Sciences (Firm)
650		0	_aDrug development _xEconomic aspects _zUnited States.
650		0	_aDrugs _xPrices _zUnited States.
650		0	_aHepatitis C _xTreatment _xPrices _zUnited States.
650		0	_aPharmaceutical industry _xEconomic aspects _zUnited States.
650		0	_aSofosbuvir _xPrices _zUnited States.
776	0	8	_aRoy, Victor, 1986- _tCapitalizing a cure _dOakland, California : University of California Press, [2023] _z9780520388727 _w(DLC) 2022023733.
776	0	8	_iOnline version:
999			_c523784 _d523784